<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">Novel 2-aminothiazole anticancer agents owning target specific advanced mechanism of action with favorable therapeutic index are considered valuable in the field of oncology-related drug discovery containing DNA intercalating agents, apoptotic/angiogenesis and cytotoxic agents, inhibitors of multiple enzyme targets such as EGFR/VGFER kinase, Akt (PKB) protein kinase, ALK/TGF-β type I receptor kinase, HDAC, B-RAF, Src and Abl kinase, tubulin polymerase, topo isomerase IV, PI3K/mTOR, NF-κβ, carbonic anhydrase, sphingosine kinase, Na
 <sup>+</sup>/K
 <sup>+</sup>-ATPase and CDK [
 <xref ref-type="bibr" rid="CR24">24</xref>].
</p>
